Centurion Wealth Management’s Vivos Therapeutics VVOS Stock Holding History

Centurion Wealth Management’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.28K	Hold	35,684	–	–	﹤0.01%	280
2026 Q2	$16.2K	Hold	35,684	–	–	﹤0.01%	283
2026 Q1	$42.1K	Buy	+35,684	New	+$57.2K	0.01%	316

Other funds holding VVOS

B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

AWA

Acorn Wealth Advisors Grand Blanc, Michigan $407M AUM 14.44% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Centurion Wealth Management's VVOS Position: Q3 2026 in Review

Centurion Wealth Management held its Vivos Therapeutics (VVOS) position steady in Q3 2026 at 35,684 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Centurion Wealth Management first reported a position in VVOS in Q1 2026 and has held it in 3 quarters since. The position peaked at $42.1K in Q1 2026. 4 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

Centurion Wealth Management held 35,684 shares of Vivos Therapeutics worth $5.28K as of Q3 2026.
Centurion Wealth Management left its Vivos Therapeutics share count unchanged in Q3 2026.
Vivos Therapeutics made up ﹤0.01% of Centurion Wealth Management's portfolio in Q3 2026, its #280 holding.
Centurion Wealth Management first reported a position in Vivos Therapeutics in Q1 2026 and has held it in 3 quarters since.
Centurion Wealth Management's Vivos Therapeutics position peaked at $42.1K in Q1 2026.
4 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.